Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression [Phase 4]
A Phase 4 clinical trial evaluating olanzapine as monotherapy for bipolar I depression has completed, reporting its efficacy as a standalone…
-
CLINICAL_TRIALS research · 2011-02-16Clinical Trial Update: Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania
This clinical trial evaluates whether brain-derived neurotrophic factor (BDNF) levels can predict treatment response in bipolar disorder, in…
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR [Phase 3]
Phase 3 trial update evaluating whether brain-derived neurotrophic factor can predict response to quetiapine XR in bipolar disorder over 16 …
-
FDA approval · 2011-02-14FDA Approved: LITHIUM CARBONATE ER — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for extended-release lithium carbonate (lithium carbonate ER), a generic form of the mood stabilizer.
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder [Phase 3]
Phase 3 randomized trial comparing a long-acting injectable form of risperidone with an oral antipsychotic for bipolar disorder has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-09Clinical Trial Update: Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression [Phase 4]
Phase 4 trial comparing venlafaxine to lamotrigine for bipolar I/II depression has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol [Phase 3]
Phase 3 study comparing risperidone to placebo for acute manic episodes in Bipolar I Disorder and assessing maintenance against haloperidol;…
-
CLINICAL_TRIALS trial_result · 2011-01-26Clinical Trial Update: Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression [Phase 3]
Phase 3 trial evaluating quetiapine fumarate (SEROQUEL) for bipolar depression has completed, with reported safety and efficacy outcomes.
-
FDA approval · 2011-01-25FDA Approved: VALPROIC ACID — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Valproic acid submitted by Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder [Phase 3]
Phase 3 trial evaluating risperidone added to mood stabilizers for manic episodes in bipolar disorder completed, assessing effectiveness and…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania [Phase 4]
Phase 4 trial evaluating risperidone as an adjunct to mood stabilizers for long-term treatment of bipolar mania has completed. The update su…
-
FDA approval · 2011-01-21FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for divalproex sodium submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder [Phase 3]
Phase 3 trial comparing risperidone to placebo for manic episodes in bipolar I disorder has completed, with an update on effectiveness and s…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder [Phase 3]
This document reports the completion of a Phase 3 trial comparing risperidone to placebo for the treatment of manic or mixed episodes in Bip…
-
FDA approval · 2011-01-13FDA Approved: LAMOTRIGINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's generic lamotrigine under an Original Application for marketing in the United States. This ap…
-
FDA approval · 2011-01-12FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited, advancing the approval status of its generic …
-
FDA approval · 2011-01-11FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone filed by ANI Pharmaceuticals, Inc., indicating an update related to the product’…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents [Phase 3]
Phase 3 safety study of sodium divalproate in adolescents with bipolar disorder has completed (sponsor: Sanofi).
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
A completed non-interventional post-marketing surveillance study assessing safety and efficacy of Zeldox Capsule in bipolar disorder and sch…
-
FDA approval · 2010-12-27FDA Approved: LITHIUM CARBONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's lithium carbonate as an original generic application, enabling a generic version of lithium carbonate to be marketed…
-
CLINICAL_TRIALS research · 2010-12-22Clinical Trial Update: A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
This is a completed non-interventional study sponsored by AstraZeneca that evaluated treatment patterns of atypical antipsychotics in adults…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 2]
Phase 2 trial results evaluating armodafinil as adjunctive treatment for major depression in adults with Bipolar I Disorder; trial completed…
-
CLINICAL_TRIALS research · 2010-12-17Clinical Trial Update: Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy [NA]
Clinical trial update discusses the role of structured group psychoeducation therapy for bipolar disorder and addressing related myths.
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment
This clinical trial update reports the completion of a Spanish validation of a questionnaire to assess patients' perceptions about antipsych…
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis [Phase 3]
A Phase 3 clinical trial (FAST-A) evaluating the efficacy and safety of Quetiapin IR in acute psychosis was terminated.